What is the recommended dose of aspirin (acetylsalicylic acid) to administer during a myocardial infarction (heart attack)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Aspirin Dosing in Acute Myocardial Infarction

Give 162 to 325 mg of non-enteric-coated aspirin immediately, chewed or crushed, with the 162 mg dose having the strongest evidence (Level A) and representing the optimal balance between efficacy and bleeding risk. 1, 2

Initial Loading Dose

  • Administer 162 to 325 mg of aspirin as soon as a heart attack is suspected, ideally in the prehospital setting or immediately upon presentation. 1, 2

  • The aspirin must be chewed or crushed (non-enteric-coated formulation) to achieve rapid buccal absorption and immediate platelet inhibition. 1, 2

  • The 162 mg dose carries Level of Evidence A support from the ACC/AHA, while the 325 mg dose has only Level of Evidence C support. 1, 2

  • Research directly comparing these doses demonstrates that 162 mg is as effective as 325 mg for mortality reduction but causes significantly less bleeding (9.3% vs 12.2% moderate/severe bleeding, adjusted OR 1.14 for 325 mg). 3

Evidence Supporting the 162 mg Dose

  • In the GUSTO I and III trials (n=48,422 STEMI patients), 162 mg aspirin showed equivalent 24-hour mortality (2.8% vs 2.9%), 7-day mortality (4.9% vs 5.2%), and 30-day mortality (6.5% vs 7.1%) compared to 325 mg, with no statistical difference after adjustment. 3

  • The 162 mg dose produces rapid and near-total inhibition of thromboxane A2 production, achieving the full clinical antithrombotic effect needed in acute MI. 1

  • When given within 24 hours of STEMI onset, aspirin reduces vascular mortality by 23% at 5 weeks. 2, 4

Maintenance Dosing After the Acute Event

  • Switch to 81 mg daily indefinitely after the initial loading dose. 1, 2, 4

  • The 81 mg maintenance dose is explicitly preferred over higher maintenance doses (such as 325 mg daily) to minimize bleeding risk while maintaining full antiplatelet efficacy. 1, 2, 4

  • This maintenance dose reduces serious vascular events by 1.5% per year in long-term secondary prevention. 2, 4

Critical Implementation Points

  • Never use enteric-coated aspirin for the loading dose as it delays absorption when immediate platelet inhibition is essential. 1, 2

  • Aspirin can and should be administered by first aid providers or EMS personnel in the prehospital setting while awaiting transport. 1

  • The only contraindications are documented aspirin allergy, active bleeding, or prior physician instruction not to take aspirin. 1

  • If the patient has already taken aspirin before presentation, do not give an additional loading dose—continue with the maintenance regimen. 1

Common Pitfalls to Avoid

  • Do not delay aspirin administration waiting for diagnostic confirmation—give it immediately when acute MI is suspected based on symptoms. 1, 2

  • Do not use higher maintenance doses (such as 325 mg daily) long-term, as meta-analyses show equivalent efficacy across doses from 75 to 1500 mg daily for secondary prevention, but higher doses increase bleeding without additional benefit. 5, 6

  • Do not give aspirin to patients with systolic blood pressure below 90 mmHg until hemodynamic stability is achieved, though this relates more to concurrent nitrate administration than aspirin itself. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Aspirin Dosing in Acute Myocardial Infarction

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Aspirin Use in Secondary Prevention for Patients with History of MI and LBBB

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Aspirin in cardiovascular disorders. What is the optimum dose?

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.